AstraZeneca's first quarter results reflect continued strong market performance
- Details
- Category: AstraZeneca

Bayer achieves strong gains in sales and earnings
- Details
- Category: Bayer

Boehringer Ingelheim grows faster than the pharmaceutical market
- Details
- Category: Boehringer Ingelheim

Despite Concern, Americans Aren't Protecting Themselves Against Diabetes
- Details
- Category: Abbott

Roche Group sustained its strong sales growth in the first three months of 2010
- Details
- Category: Roche

Novo Nordisk's operating profit increased by 15% in the first quarter of 2010
- Details
- Category: Novo Nordisk

Novartis healthcare portfolio generates strong growth in first quarter of 2010
- Details
- Category: Novartis

More Pharma News ...
- World Bank and Pfizer Announce Initiative to Help Improve Healthcare Delivery
- Superior efficacy of Victoza® (liraglutide) compared to Januvia® (sitagliptin)
- Pfizer Discontinues Phase 3 Trial of Sutent® in Advanced Hepatocellular Carcinoma
- Amgen's First Quarter 2010 Revenue Increased 9 Percent to $3.6 Billion
- Abbott Reports Strong First Quarter Results
- Sandoz to acquire Oriel Therapeutics, gaining rights to portfolio of respiratory products
- Bayer HealthCare Marks 2010 World Hemophilia Day with EUR 250,000 Contribution